As a leader in computational EEG, Evoke Neuroscience is focused on making brain health scans routine to help reduce the number of people living with treatable cognitive impairment.
Homepage
- Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413–446 (2020).
- Foster, N. L. et al. Quality improvement in neurology: Mild cognitive impairment quality measurement set. Neurology 93, 705–713 (2019).
providers page
- Foster, N. L. et al. Quality improvement in neurology: Mild cognitive impairment quality measurement set. Neurology 93, 705–713 (2019).
- Houmani, N. et al. Diagnosis of Alzheimer’s disease with electroencephalography in a differential framework. PLoS One 13, e0193607 (2018).
- Alzheimer’s Association. 2018 Alzheimer’s Disease Facts and Figures. Alzheimers Dement 14, 367–429 (2018).
- Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413–446 (2020).
- Alzheimer’s Association. 2020 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dement. 16, 391+ (2020).
science page
- Horvath, A. et al. EEG and ERP biomarkers of Alzheimer’s disease: A critical review. Front. Biosci. 23, 183–220 (2018).
- Babiloni, C. et al. Classification of single normal and Alzheimer’s disease individuals from cortical sources of resting state EEG rhythms. Front. Neurosci. 10, (2016).
- Neto, E., Allen, E. A., Aurlien, H., Nordby, H. & Eichele, T. EEG spectral features discriminate between Alzheimer’s and vascular dementia. Front. Neurol. 6, 1–9 (2015).
- Kwak, Y. T. Quantitative EEG findings in different stage of Alzheimer’s Disease. J. Clin. Neurophysiol. 23, 457–462 (2006).
- Monastra, V. J. et al. Assessing attention deficit hyperactivity disorder via quantitative electroencephalography: An initial validation study. Neuropsychology 13, 424–433 (1999).
- Monastra, V. J., Lubar, J. F. & Linden, M. The development of a quantitative electroencephalographic scanning process for attention deficit-hyperactivity disorder: Reliability and validity studies. Neuropsychology 15, 136–144 (2001).
- Polich, J. Updating P300: An integrative theory of P3a and P3b. Clin. Neurophysiol. 118, 2128–2148 (2007).
- Bennys, K., Rondouin, G., Benattar, E., Gabelle, A. & Touchon, J. Can event-related potential predict the progression of mild cognitive impairment? J. Clin. Neurophysiol. 28, 625–632 (2011).
- Olichney, J. M. & Hillert, D. G. Clinical applications of cognitive event-related potentials in Alzheimer’s disease. Phys. Med. Rehabil. Clin. N. Am. 15, 205–233 (2004).
- Cecchi, M. et al. A clinical trial to validate event-related potential markers of Alzheimer’s disease in outpatient settings. Alzheimer’s Dement. 1, 1–8 (2015).
- Gorus, E., De Raedt, R., Lambert, M., Lemper, J.-C. & Mets, T. Reaction times and performance variability in normal aging, Mild Cognitive Impairment, and Alzheimer’s disease. J. Geriatr. Psychiatry Neurol. 21, 204–218 (2008).
- Tamm, L. et al. Reaction time cariability in ADHD: A review. Neurotherapeutics 9, 500–508 (2012).
- Ballard, J. C. Assessing attention: Comparison of response-inhibition and traditional continuous performance tests. J. Clin. Exp. Neuropsychol. 23, 331–350 (2001).
- Alzheimer’s Association. 2020 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dement. 16, 391+ (2020).
- Alzheimer’s Association. 2019 Alzheimer’s Disease Facts and Figures. Alzheimers Dement 15, 321–87 (2019).
- Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413–446 (2020).
- Ngandu, T. et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 15, 1–9 (2015).
- Walsh, C., Drinkenburg, W. H. I. M. & Ahnaou, A. Neurophysiological assessment of neural network plasticity and connectivity: Progress towards early functional biomarkers for disease interception therapies in Alzheimer’s disease. Neurosci. Biobehav. Rev. 73, 340–358 (2017).
